Filing Details

Accession Number:
0001920179-23-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-11 15:07:59
Reporting Period:
2022-11-30
Accepted Time:
2023-01-11 15:07:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1872812 Tc Biopharm (Holdings) Plc TCBP Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1929926 Edward Kenneth Randall Renaissance Capital Partners Ltd
42 Shad Thames
London, X0 Se1 2Yd X0
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares [Ads] Acquisiton 2022-11-30 70,000 $5.00 382,963 No 4 P Indirect By Renaissance Capital Partners Ltd
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Renaissance Capital Partners Ltd
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Series A Warrants Acquisiton 2022-11-30 70,000 $0.00 70,000 $5.00
Ordinary Shares Series B Warrants Acquisiton 2022-11-30 70,000 $0.00 70,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,000 2022-11-30 2028-05-30 No 4 P Indirect
70,000 2022-11-30 2025-05-30 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares [Ads] 2,008 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Warrants $4.25 2022-04-11 2028-02-10 106,129 106,129 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-02-10 106,129 106,129 Indirect
Footnotes
  1. Series A Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of %5.00.
  2. Series B Warrants were issued as part of a unit comprised of one Ordinary Share, one Series A Warrant, and one Series B Warrant, with a purchase price per unit of %5.00.